In the present study, RNA interference (RNAi) technology was used to inhibit the expression of the Nanog gene to study the effect on the tumor biological behavior of the gastric cancer cell line SGC-7901; the aim was to provide an experimental basis for the application of the RNAi technique as a gene therapy method for gastric cancer. The gene discussed is NANOG; the disease is gastric cancer.